Cargando...
Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial
PURPOSE: Local/systemic symptoms during cancer therapy may be exacerbated by dysregulated inflammation and its downstream toxic effects. Minocycline can suppress proinflammatory cytokine release; therefore, we investigated its potential to reduce patient-reported symptom severity during radiotherapy...
Gardado en:
| Publicado en: | Support Care Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470188/ https://ncbi.nlm.nih.gov/pubmed/31037378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04791-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|